ESG Data Guide 2024

Inrate AG - Adverse Product Screening

Data category

Research data

The data offers solutions for:

  • Investment decisions and portfolio insight
  • Norms-based screening

Who are the data users?

  • Financial institutions
  • Investors

Brief description of the data offering

Inrate maps 10,000+ companies' revenue streams to business activities. This enables us to seamlessly screen companies that are involved in standard adverse products (controversial weapons, GMOs, energy and extractives, etc,.) while also providing customisable product screening based on your specific investor values. Our granularity goes beyond the basic categorisation, enabling you to screen based on specific criteria. For example, you can choose to screen companies involved in the genetic modifications of animal and human species while including companies that are involved in the genetic modifications of plant species.

Inrate evaluates an organisation’s involvement in products having adverse environmental or social impacts, employing a comprehensive screening approach that encompasses 10 adverse product categories along with additional sub-products: genetic engineering, nuclear energy, defence, fossil fuels, alcohol, adult entertainment, pesticides, tobacco, gambling, palm oil.​

Where and how do you source your data?

Inrate uses publicly available company-reprted information (sustainability reports, annual reports, etc.).

What is the cost for your data offering?

Cost is driven by product, coverage, granularity of the data, use case and any customisation. Contact for more details. 



Alexandra Finkestein-Feller (Senior Business Development Manager): 

Atulya Vajapeyam (Senior Business Development Manager):